These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 19931262)

  • 21. Correlation of Bone Mineral Density Scores and Proton Pump Inhibitors Use in the Elderly.
    Amoako AO; Jafilan L; Nasiri P; Pujalte GG
    Curr Rheumatol Rev; 2016; 12(2):162-6. PubMed ID: 26496778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.
    Heijckmann AC; Huijberts MS; Geusens P; de Vries J; Menheere PP; Wolffenbuttel BH
    Eur J Endocrinol; 2005 Jul; 153(1):23-9. PubMed ID: 15994742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticosteroid effects on proximal femur bone loss.
    Sambrook P; Birmingham J; Kempler S; Kelly P; Eberl S; Pocock N; Yeates M; Eisman J
    J Bone Miner Res; 1990 Dec; 5(12):1211-6. PubMed ID: 2075834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.
    Moberg LM; Nilsson PM; Samsioe G; Borgfeldt C
    Maturitas; 2014 Aug; 78(4):310-5. PubMed ID: 24958166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pattern of bone mineral density in idiopathic male osteoporosis.
    Laroche M
    Rheumatol Int; 2012 Oct; 32(10):3093-6. PubMed ID: 21918900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of five phalangeal QUS parameters in the evaluation of gonadal-status, age and vertebral fracture risk compared with DXA.
    Albanese CV; Cepollaro C; de Terlizzi F; Brandi ML; Passariello R
    Ultrasound Med Biol; 2009 Apr; 35(4):537-44. PubMed ID: 19097682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss.
    Nguyen TV; Sambrook PN; Eisman JA
    J Bone Miner Res; 1997 Jan; 12(1):124-35. PubMed ID: 9240735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton Pump Inhibitor Use and Bone Health in Patients With Rheumatic Diseases: A Cross-Sectional Study.
    Palmowski A; Schmajuk G; Yazdany J; Katz P; Li J; Stovall R; Kersey E; Nielsen SM; Christensen R; Bliddal H; Boyadzhieva Z; Schneider U; Alexander T; Muche B; Hermann S; Wiebe E; Buttgereit F
    Mayo Clin Proc; 2024 Jul; 99(7):1046-1057. PubMed ID: 38752948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid-suppressive medications and risk of bone loss and fracture in older adults.
    Yu EW; Blackwell T; Ensrud KE; Hillier TA; Lane NE; Orwoll E; Bauer DC
    Calcif Tissue Int; 2008 Oct; 83(4):251-9. PubMed ID: 18813868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lumbar spine and hip bone mineral density in Thai women using the Osteosys Dexxum T-bone densitometer.
    Pongchaiyakul C; Kotruchin P
    J Med Assoc Thai; 2013 Aug; 96(8):898-904. PubMed ID: 23991594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound analyses of the calcaneus predict relative risk of the presence of at least one vertebral fracture and reflect different physical qualities of bone in different regions of the skeleton.
    Pfeifer M; Pollaehne W; Minne HW
    Horm Metab Res; 1997 Feb; 29(2):76-9. PubMed ID: 9105904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beverage-specific alcohol intake and bone loss in older men and women: a longitudinal study.
    Yin J; Winzenberg T; Quinn S; Giles G; Jones G
    Eur J Clin Nutr; 2011 Apr; 65(4):526-32. PubMed ID: 21326269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Femoral bone mineral density, neck-shaft angle and mean femoral neck width as predictors of hip fracture in men and women. Multicenter Project for Research in Osteoporosis.
    Alonso CG; Curiel MD; Carranza FH; Cano RP; Peréz AD
    Osteoporos Int; 2000; 11(8):714-20. PubMed ID: 11095176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
    Rehman Q; Lang T; Modin G; Lane NE
    Arthritis Rheum; 2002 May; 46(5):1292-7. PubMed ID: 12115236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased frequency of osteoporosis and BMD below the expected range for age among South Korean women with rheumatoid arthritis.
    Lee SG; Park YE; Park SH; Kim TK; Choi HJ; Lee SJ; Kim SI; Lee SH; Kim GT; Lee JW; Lee JH; Baek SH
    Int J Rheum Dis; 2012 Jun; 15(3):289-96. PubMed ID: 22709491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study.
    Hannan MT; Felson DT; Dawson-Hughes B; Tucker KL; Cupples LA; Wilson PW; Kiel DP
    J Bone Miner Res; 2000 Apr; 15(4):710-20. PubMed ID: 10780863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of proton pump-inhibiting drugs on mineral metabolism.
    Insogna KL
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S2-4. PubMed ID: 19262542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study.
    Richards JB; Joseph L; Schwartzman K; Kreiger N; Tenenhouse A; Goltzman D;
    Osteoporos Int; 2006; 17(9):1410-9. PubMed ID: 16791706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fracture risk and bone mineral density reduction associated with proton pump inhibitors.
    Lau YT; Ahmed NN
    Pharmacotherapy; 2012 Jan; 32(1):67-79. PubMed ID: 22392829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rates of bone loss among women initiating antidepressant medication use in midlife.
    Diem SJ; Ruppert K; Cauley JA; Lian Y; Bromberger JT; Finkelstein JS; Greendale GA; Solomon DH
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4355-63. PubMed ID: 24001746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.